CoChat

Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The aim of this study is to provide reliable regression-based estimates of costs associated with different type 2 diabetes complications. RESEARCH DESIGN AND METHODS: We used nationwide statutory health insurance (SHI) data from 316,220 patients with type 2 diabetes. Costs for inpatient and outpatient care, pharmaceuticals, rehabilitation, and nonmedical aids and appliances were assessed in the years 2013–2015. Quarterly observations are available for each year. We estimated costs (in 2015 euro) for complications using a generalized estimating equations model with a normal distribution adjusted for age, sex, occurrence of different complications, and history of complications at baseline, 2012. Two- and threefold interactions were included in an extended model. RESULTS: The base case model estimated total costs in the quarter of event for the example of a 60- to 69-year-old man as follows: diabetic foot €1,293, amputation €14,284, retinopathy €671, blindness €2,933, nephropathy €3,353, end-stage renal disease (ESRD) €22,691, nonfatal stroke €9,769, fatal stroke €11,176, nonfatal myocardial infarction (MI)/cardiac arrest (CA) €8,035, fatal MI/CA €8,700, nonfatal ischemic heart disease (IHD) €6,548, fatal IHD €20,942, chronic heart failure €3,912, and angina pectoris €2,695. In the subsequent quarters, costs ranged from €681 for retinopathy to €6,130 for ESRD. CONCLUSIONS: Type 2 diabetes complications have a significant impact on total health care costs in the SHI system, not only in the quarter of event but also in subsequent years. Men and women from different age-groups differ in their costs for complications. Our comprehensive estimates may support the parametrization of diabetes models and help clinicians and policy makers to quantify the economic burden of diabetes complications in the context of new prevention and treatment programs.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc17-1763

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 3

  1. Tamayo, 2016, The prevalence and incidence of diabetes in Germany, Dtsch Arztebl Int, 113, 177
  2. Chang, 2012, Validating the adapted Diabetes Complications Severity Index in claims data, Am J Manag Care, 18, 721
  3. Robert Koch Institute, 2014, Diabetes Mellitus: Fact Sheet for GEDA 2012: Results of the “Health in Germany Study 2012.”

Cited by

See all 141

Metadata

Authors
Kähm, K., Laxy, M., Schneider, U., Rogowski, W. H., Lhachimi, S. K., & Holle, R.
Affiliations
  • Helmholtz Munich (DE)
  • Techniker Krankenkasse (Germany) (DE)
  • University of Bremen (DE)
Corresponding author
Kähm, Katharina
Venue
Diabetes Care
Published
2018-01-18
Volume
41
Issue
5
Pages
971-978
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2789481148
Cited by
141
References
33
Citations by year
2026: 6 · 2025: 9 · 2024: 12 · 2023: 19 · 2022: 24 · 2021: 20 · 2020: 29 · 2019: 13 · 2018: 9
FWCI
27.03
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • Site cant be reached (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords
type 2 diabetes, diabetes complications, health care costs, economic burden of disease, diabetic foot, amputation, diabetic retinopathy, blindness, diabetic nephropathy, end-stage renal disease, stroke, myocardial infarction, ischemic heart disease, chronic heart failure, angina pectoris, sex differences, age differences, statutory health insurance, Germany
MeSH terms
Aged, Ambulatory Care, Amputation, Surgical, Diabetes Mellitus, Type 2, Female, Germany, Heart Failure, Humans, Male, Middle Aged, Myocardial Infarction, Health Care Costs, Diabetic Foot, Stroke, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. https://app.cochat.ai/papers/10.2337/dc17-1763
The paper
Kähm, K., Laxy, M., Schneider, U., Rogowski, W. H., Lhachimi, S. K., & Holle, R. (2018). Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes Care. https://doi.org/10.2337/dc17-1763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.